As GLP-1 use and metabolic health challenges rise, employers increasingly seek scalable solutions to support their workforce and manage healthcare costs
As liraglutide is a peptide, it has the potential to be immunogenic
Regulatory Approvals and Guidelines: As GLP-1 receptor agonists receive more regulatory approvals and are recommended in treatment guidelines for diabetes management, their adoption in clinical practice continues to grow, further solidifying their position in the market
If it was something I could control, Id be controlling it without medication, says Diana Edelman, a 43-year old food and travel writer taking Mounjaro
Abgerufen auf ncbi.nlm.nih.gov Pyo, H
This is not incremental progress